Sign in Subscribe
Apoptosis

Ovarian Cancer Research Reveals Promising New Therapeutic Agent

Strategic Insights

— 1 min read

Researchers at Daegu Catholic University in Gyeongsan, South Korea, have made a breakthrough discovery in the fight against ovarian cancer. The team found that a compound called corylin, derived from the fruit of a plant, exhibits significant anticancer activity by inducing apoptosis and cell cycle arrest in ovarian cancer cells. This finding has the potential to lead to the development of a new therapeutic agent for the treatment of ovarian cancer, a disease that is currently the leading cause of death among gynecological malignancies worldwide.

Key Takeaways:

  • The study employed SKOV3 cells to investigate the anticancer activity of corylin, a principal flavonoid isolated from the fruit of a plant.
  • Corylin was found to inhibit SKOV3 cell proliferation and colony formation in a dose-dependent manner, inducing apoptosis through the activation of caspases and disruption of the mitochondrial membrane potential.
  • The compound also caused G0/G1 cell cycle arrest by modifying the levels of cyclin D1 and the phosphorylated retinoblastoma protein.
  • Further mechanistic studies demonstrated a marked downregulation of Signal transducer and activator of transcription 3 (STAT3) phosphorylation, nuclear localization, and target gene expression in corylin-treated SKOV3 cells.
  • The research concluded that corylin is a promising therapeutic agent for inhibiting cancer cell proliferation by targeting STAT3 in ovarian cancer.
  • The study's findings have been peer-reviewed and published in the journal Biomolecules & Therapeutics.

Statistics:

  • Ovarian cancer is the leading cause of death among gynecological malignancies worldwide (Source: Daegu Catholic University).
  • Corylin was found to inhibit SKOV3 cell proliferation by 50% at a concentration of 20 μM (Source: Biomolecules & Therapeutics).
  • The compound induced apoptosis in a dose-dependent manner, with a maximum effect observed at a concentration of 40 μM (Source: Biomolecules & Therapeutics).
  • The study demonstrated a marked downregulation of STAT3 phosphorylation in corylin-treated SKOV3 cells, suggesting a potential therapeutic target for ovarian cancer treatment (Source: Biomolecules & Therapeutics).

Sources:

  • Corylin Exhibits Anticancer Activity by Inducing Apoptosis and G0/G1 Cell Cycle Arrest in SKOV3 Human Ovarian Cancer Cells. Biomolecules & Therapeutics. 2025.
  • NewsRx. Recent Findings from Daegu Catholic University Advance Knowledge in Ovarian Cancer (Corylin Exhibits Anticancer Activity by Inducing Apoptosis and G0/G1 Cell Cycle Arrest in SKOV3 Human Ovarian Cancer Cells). OBGYN & Reproduction Week. October 27, 2025; p 597.

Read more